prostate cancer prostate cancer peripheral neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Prostate cancer patients to whom docetaxel / prednin therapy is introduced 2) Patients who are over 20 years old and have given their written consent 3) Hand size patients within the size range of commercially available surgical gloves. 4) Protect X Intense pressure support (ML size; height less than 178cm, calf circumference less than 44cm, thigh circumference less than 52cm, foot size 25 to 28cm), Protect X Intense pressure support (L-LL size; height more than 175cm calf Patients who can wear around 42cm to 52cm around the thigh, around 50 to 62cm around the thigh and 27 to 30cm of foot size)
Exclusion criteria
Exclusion criteria: 1) Patients with peripheral neuropathy at the start of the study 2) Patients who have received medications that may cause peripheral neuropathy in the past. 3) Patients with extremely small or large hands that fall outside the size range of commercially available surgical gloves. 4) Patients with extreme finger and leg deformities 5) Patients with acute deep vein thrombosis 6) Patients with thrombophlebitis of the superficial vein of lower limb 7) Patients with arterial circulation disorders such as obstructive arteriosclerosis, congestive heart failure, inflammatory or purulent diseases of lower limbs, and acute wounds 8) Patients with necrosis / gangrene, severe edema, purulent skin disease after skin transplantation 9) Diabetic patients with peripheral neuropathy 10) Patient whose ankle circumference exceeds 27cm 11) Other patients judged by the investigator to be inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| peripheral neuropathy | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the claw | — |
Contacts
Kagawa university hospital